Telehealth-Clinical Advocacy Project
(T-CAP)
1 other identifier
interventional
8
1 country
1
Brief Summary
The purpose of this study is to develop a clinical telehealth intervention and test the feasibility of integrating telehealth within a police opioid county diversion program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2021
CompletedFirst Posted
Study publicly available on registry
June 3, 2021
CompletedStudy Start
First participant enrolled
June 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedResults Posted
Study results publicly available
April 18, 2025
CompletedApril 18, 2025
April 1, 2025
2.1 years
April 5, 2021
December 13, 2024
April 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percent of Participants Who Received One or More Referrals During the 12-week Intervention.
The number of participants who received one or more referrals to services made by the intervention coach. This measure is collected as evidence supporting participant utilization of the app and the coaching support model.
12-week intervention period
Texas Christian University Drug Screen 5 Severity Score From Baseline to Post Intervention at Week 12
The Texas Christian University Drug Screen 5 is a 19-question survey that captures substance use during the past 12 months. Interpretation of the TCU Drug Screen 5 score for drug use severity corresponds with the Diagnostic and Statistical Manual of Mental Disorders 5 criteria for reporting three possible severity levels (mild, moderate, severe). A single level score is based on participant responses to 11 items (total range: 0 to 11) as such: the presence of 2 to 3 endorsed symptoms is scored as a mild disorder; 4 to 5 endorsed symptoms is scored as moderate disorder; and a severe disorder is scored with the presence of 6 or more symptoms of the 11 items; thus, more endorsed items means a more serious drug use problem.
Texas Christian University Drug Screen 5 data are reported for baseline and end-of-intervention at 12 weeks after consent.
Study Arms (1)
Treatment plus telehealth
EXPERIMENTALIndividuals will receive telehealth support services, including seven brief motivational interviewing sessions, delivered by a licensed substance use counselor via live interactive video calls during the 12-week intervention.
Interventions
The telehealth intervention is delivered with an app developed for this research. The intervention features live video calling, messaging, appointment reminders; clinical support is provided by licensed clinicians.
Eligibility Criteria
You may qualify if:
- Individuals interested in joining the study will be
- Enrolled in the A Way Out Opioid Diversion Program (ODP),
- At least 18 years of age,
- Able to speak and understand English,
- Have a history of opioid, alcohol, or other substance use within last 12 months,
- Be willing to provide the research team with access to treatment records,
- Have access to a phone, tablet or computer for the informed consent activity, and
- Have a mailing address to receive a study phone issued to consented participants
You may not qualify if:
- Individuals not eligible for the study are
- Not currently enrolled in the A Way Out Opioid Diversion Program on the day of consent,
- Under the age of 18 on the day of consent,
- Unable to speak and understand English,
- Have a history of past opioid, alcohol, or other substance use longer than 12 months ago with no use of opioids in the last 12 months,
- Unwilling to authorize the research team to access treatment records,
- Without access to a phone, tablet or computer to complete the informed consent activity,
- Without a mailing address
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lake County Public Health Department
Waukegan, Illinois, 60085, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The T-CAP project explored the feasibility of implementing a telehealth model in a police diversion program that supports adults in recovery from opioid use disorder with treatment as an alternative to arrest. Inadequate data collection due to enrollment well below the target during the 2019 pandemic limits the ability to draw meaningful conclusions about the impact of the intervention to support people in recovery.
Results Point of Contact
- Title
- Dr.Jennifer Pankow
- Organization
- Texas Christian University Institute of Behavioral Research
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Pankow, PhD
Texas Christian University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2021
First Posted
June 3, 2021
Study Start
June 14, 2021
Primary Completion
July 31, 2023
Study Completion
July 31, 2023
Last Updated
April 18, 2025
Results First Posted
April 18, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share